Literature DB >> 11591456

Altered expression of apolipoprotein E, amyloid precursor protein and presenilin-1 is associated with chronic reactive gliosis in rat cortical tissue.

R N Martins1, K Taddei, C Kendall, G Evin, K A Bates, A R Harvey.   

Abstract

A major characteristic feature of Alzheimer's disease is the formation of compact, extracellular deposits of beta-amyloid (senile plaques). These deposits are surrounded by reactive astrocytes, microglia and dystrophic neurites. Mutations in three genes have been implicated in early-onset familial Alzheimer's disease. However, inflammatory changes and astrogliosis are also believed to play a role in Alzheimer's pathology. What is unclear is the extent to which these factors initiate or contribute to the disease progression. Previous rat studies demonstrated that heterotopic transplantation of foetal cortical tissue onto the midbrain of neonatal hosts resulted in sustained glial reactivity for many months. Similar changes were not seen in cortex-to-cortex grafts. Using this model of chronic cortical gliosis, we have now measured reactive changes in the levels of the key Alzheimer's disease proteins, namely the amyloid precursor protein, apolipoprotein E and presenilin-1. These changes were visualised immunohistochemically and were quantified by western blot analysis. We report here that chronic cortical gliosis in the rat results in a sustained increase in the levels of apolipoprotein E and total amyloid precursor protein. Reactive astrocytes in heterotopic cortical grafts were immunopositive for both of these proteins. Using a panel of amyloid precursor protein antibodies we demonstrate that chronic reactive gliosis is associated with alternative cleavage of the peptide. No significant changes in apolipoprotein E or amyloid precursor protein expression were seen in non-gliotic cortex-to-cortex transplants. Compared to host cortex, the levels of both N-terminal and C-terminal fragments of presenilin-1 were significantly lower in gliotic heterotopic grafts.The changes described here largely mirror those seen in the cerebral cortex of humans with Alzheimer's disease and are consistent with the proposal that astrogliosis may be an important factor in the pathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11591456     DOI: 10.1016/s0306-4522(01)00289-5

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  8 in total

1.  Amyloid precursor protein revisited: neuron-specific expression and highly stable nature of soluble derivatives.

Authors:  Qinxi Guo; Hongmei Li; Samson S K Gaddam; Nicholas J Justice; Claudia S Robertson; Hui Zheng
Journal:  J Biol Chem       Date:  2011-12-05       Impact factor: 5.157

2.  Toxicogenomic studies of the rat brain at an early time point following acute sarin exposure.

Authors:  Tirupapuliyur V Damodaran; Stephen T Greenfield; Anand G Patel; Holly K Dressman; Siomon K Lin; Mohamed B Abou-Donia
Journal:  Neurochem Res       Date:  2006-05-13       Impact factor: 3.996

Review 3.  Astrocytes in Alzheimer's disease.

Authors:  Alexei Verkhratsky; Markel Olabarria; Harun N Noristani; Chia-Yu Yeh; Jose Julio Rodriguez
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

4.  Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.

Authors:  Yu-Wen Alvin Huang; Bo Zhou; Amber M Nabet; Marius Wernig; Thomas C Südhof
Journal:  J Neurosci       Date:  2019-07-22       Impact factor: 6.167

5.  Ovariectomy and 17beta-estradiol replacement do not alter beta-amyloid levels in sheep brain.

Authors:  A M Barron; M Cake; G Verdile; R N Martins
Journal:  Endocrinology       Date:  2009-03-12       Impact factor: 4.736

Review 6.  Astroglia in Alzheimer's Disease.

Authors:  Alexei Verkhratsky; Vladimir Parpura; Jose Julio Rodriguez-Arellano; Robert Zorec
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

7.  C/EBPβ is a key transcription factor for APOE and preferentially mediates ApoE4 expression in Alzheimer's disease.

Authors:  Yiyuan Xia; Zhi-Hao Wang; Jichun Zhang; Xia Liu; Shan Ping Yu; Karen X Ye; Jian-Zhi Wang; Keqiang Ye; Xiao-Chuan Wang
Journal:  Mol Psychiatry       Date:  2020-12-18       Impact factor: 15.992

Review 8.  Cellular Reprogramming and Its Potential Application in Alzheimer's Disease.

Authors:  Chao Zhou; Wanyan Ni; Taiyang Zhu; Shuyu Dong; Ping Sun; Fang Hua
Journal:  Front Neurosci       Date:  2022-04-07       Impact factor: 5.152

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.